PTGS2 and carcinoma: Since COX-2 is a novel marker that can be used as a prognostic marker, further helping in evaluating the treatment options for patients with carcinoma breast, more studies are required with the precise predictive significance of COX-2 in relation to multiple additional factors that will help in the treatment of human breast cancer.